Life Science News

Latest updates from the biotech and pharma world

BioPharma Dive 2025-12-11

Biotech venture firm Apple Tree goes bankrupt amid dispute with billionaire backer

BioPharma Dive 2025-12-11

Lilly’s three-pronged drug puts obesity field ‘on notice’

BioPharma Dive 2025-12-11

Crapo, Cassidy propose enhanced ACA subsidy alternative

BioPharma Dive 2025-12-11

Prolynx banks $70M for longer-lasting obesity drugs

BioPharma Dive 2025-12-10

FDA approves first drug in National Priority Voucher program

BioPharma Dive 2025-12-10

A former Roivant spinout bets on AI-designed drugs for immune conditions

BioPharma Dive 2025-12-09

Novartis notches another win for drug acquired in MorphoSys deal

BioPharma Dive 2025-12-09

Pfizer dips into China for another try at an obesity pill

BioPharma Dive 2025-12-09

FDA raises CAR-T approval standards; Novartis bets on an AI startup

BioPharma Dive 2025-12-09

J&J’s ‘remarkable’ Tecvayli data support earlier use in multiple myeloma

BioPharma Dive 2025-12-08

Terns drug shows potential to challenge Novartis’ blockbuster leukemia treatment

BioPharma Dive 2025-12-08

Mirum gains a hepatitis D drug in $620M buyout of startup Bluejay

BioPharma Dive 2025-12-08

Dyne to seek Duchenne drug approval; Kymera, Wave and Structure shares soar

BioPharma Dive 2025-12-08

How digital companion apps unlock value across the drug lifecycle

BioPharma Dive 2025-12-07

At ASH, Lilly makes case to widen Jaypirca use in leukemia, lymphoma

BioPharma Dive 2025-12-06

Vertex CRISPR therapy hits early goal in children with blood disorders

BioPharma Dive 2025-12-05

RFK Jr.’s hand-picked panel questions childhood vaccine schedule

BioPharma Dive 2025-12-05

Hemophilia gene therapies are struggling on the market, even as innovation soars

BioPharma Dive 2025-12-05

Praxis soars higher; Bristol Myers’ CAR-T therapy wins broader use

BioPharma Dive 2025-12-04

CDC panel again postpones vote on newborns’ hepatitis B shot

11 / 14